| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Universität Würzburg, Medizinische Klinik & Poliklinik II, Institut für Hygiene und Mikrobiologie, 97070 Würzburg; Staufer-Klinik Schwäbisch Gmünd, Innere Medizin, 73557 Mutlangen
* To whom correspondence should be addressed. Email: loeffler_j{at}klinik.uni-wuerzburg.de.
| Abstract |
|---|
Mycophenolic acid (MPA) is clinically used to prevent graft rejection but may increase the risk of fungal infection. We observed that MPA enhanced the Aspergillus fumigatus-induced oxidative burst of polymorphonuclear neutrophils but without a corresponding increase in fungal killing. Further, MPA inhibited pro-inflammatory cytokine response and maturation of dendritic cells.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |